---
title: "12 Health Care Stocks Moving In Friday's Intraday Session"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/304673410.md"
description: "In Friday's intraday session, several healthcare stocks experienced significant volatility following Q3 earnings reports. Gainers included Obsidian Therapeutics (+27.7%), TransMedics Group (+23.73%), CryoPort (+20.68%), Dogwood Therapeutics (+20.67%), Fulgent Genetics (+19.48%), and CG Oncology (+19.02%). Conversely, major losers were AirSculpt Technologies (-57.8%), Biodesix (-50.41%), Baird Medical Investment (-44.9%), CVRx (-42.76%), Virax Biolabs Group (-38.23%), and Bristol-Myers Squibb Celegne Contingent Value Rights (-34.89%)."
datetime: "2026-11-06T17:05:45.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/304673410.md)
  - [en](https://longbridge.com/en/news/304673410.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/304673410.md)
generator: "portal-rs"
---

# 12 Health Care Stocks Moving In Friday's Intraday Session

### Gainers

-   **Obsidian Therapeutics** (NASDAQ:OBX) stock increased by 27.7% to $12.26 during Friday's regular session. The company's market cap stands at $593.0 million.
-   **TransMedics Group** (NASDAQ:TMDX) shares rose 23.73% to $85.36. The market value of their outstanding shares is at $2.3 billion. As per the news, the Q3 earnings report came out yesterday.
-   **CryoPort** (NASDAQ:CYRX) shares moved upwards by 20.68% to $19.37. The market value of their outstanding shares is at $812.9 million. As per the press release, Q3 earnings came out yesterday.
-   **Dogwood Therapeutics** (NASDAQ:DWTX) shares increased by 20.67% to $1.25. The company's market cap stands at $39.7 million. As per the news, the Q3 earnings report came out yesterday.
-   **Fulgent Genetics** (NASDAQ:FLGT) shares moved upwards by 19.48% to $22.3. The market value of their outstanding shares is at $576.8 million. The company's, Q3 earnings came out yesterday.
-   **CG Oncology** (NASDAQ:CGON) stock rose 19.02% to $77.12. The market value of their outstanding shares is at $5.7 billion. The company's, Q3 earnings came out today.

### Losers

-   **AirSculpt Technologies** (NASDAQ:AIRS) stock fell 57.8% to $0.61 during Friday's regular session. The market value of their outstanding shares is at $103.8 million. As per the news, the Q3 earnings report came out today.
-   **Biodesix** (NASDAQ:BDSX) shares declined by 50.41% to $9.84. The market value of their outstanding shares is at $205.4 million. As per the press release, Q3 earnings came out yesterday.
-   **Baird Medical Investment** (NASDAQ:BDMD) shares declined by 44.9% to $0.09. The company's market cap stands at $5.0 million.
-   **CVRx** (NASDAQ:CVRX) stock declined by 42.76% to $0.84. The company's market cap stands at $39.0 million. As per the news, the Q3 earnings report came out yesterday.
-   **Virax Biolabs Group** (NASDAQ:VRAX) shares declined by 38.23% to $0.73.
-   **Bristol-Myers Squibb Company Celegne Contingent Value Rights** (NYSE:CELGR) shares fell 34.89% to $0.14. **See Also:** www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

### Related Stocks

- [AIRS.US](https://longbridge.com/en/quote/AIRS.US.md)
- [BDMD.US](https://longbridge.com/en/quote/BDMD.US.md)
- [BDSX.US](https://longbridge.com/en/quote/BDSX.US.md)
- [CGON.US](https://longbridge.com/en/quote/CGON.US.md)
- [CVRX.US](https://longbridge.com/en/quote/CVRX.US.md)
- [CYRX.US](https://longbridge.com/en/quote/CYRX.US.md)
- [DWTX.US](https://longbridge.com/en/quote/DWTX.US.md)
- [FLGT.US](https://longbridge.com/en/quote/FLGT.US.md)
- [OBX.US](https://longbridge.com/en/quote/OBX.US.md)
- [TMDX.US](https://longbridge.com/en/quote/TMDX.US.md)
- [VRAX.US](https://longbridge.com/en/quote/VRAX.US.md)

## Related News & Research

- [CVRx Participates in Fireside Chat at Piper Sandler Healthcare Conference](https://longbridge.com/en/news/305871317.md)
- [This biotech stock is up 291% from its IPO price. It’s on pace for a record closing high](https://longbridge.com/en/news/305706717.md)
- [Possible Bearish Signals With Fulgent Genetics Insiders Disposing Stock](https://longbridge.com/en/news/305816578.md)
- [CVRX: Barostim’s growth push faces specialist staffing and payer-access headwinds](https://longbridge.com/en/news/306130099.md)
- [Virax Biolabs Presents Plans for 2027 U.S. Diagnostic Testing Launch](https://longbridge.com/en/news/305974687.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**